Tel Aviv-based startup that uses AI to build digital models of the human immune system and diseases inks multi-million-dollar with French drugmaker

US pharmaceutical giant to make $20m equity investment, part of larger agreement to license tech and collaborate on R&D

Tel Aviv-based startup uses machine learning to build computational models of human diseases to speed up treatment discoveries

Tel Aviv-based startup uses machine learning to build computational models of human immune system and diseases to speed up treatments

Tel Aviv-based startup uses AI to build digital models of the human immune system and diseases to speed up treatments; two firms will test out new drugs